Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company based in New York City, focused on pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease [3] - The company employs a stepwise development approach, utilizing early proof-of-concept functional and biomarker data to advance its pipeline of programs [3] Upcoming Event - R. Nolan Townsend, the CEO of Lexeo Therapeutics, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at 8:15 AM PT in San Francisco, California [1] - The presentation will be available via live webcast on the company's website, with a replay accessible afterward [2]